Asia Pacific Neurostimulation Devices Market By Devices (Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators and Other Devices) By Applications (Pain Management, Hearing Loss, Urinary Incontinence, Parkinson's Disease, Epilepsy and Other Applications) By Country, Industry Analysis and Forecast, 2020 - 2026
The Asia Pacific Neurostimulation Devices Market would witness market growth of 13.9% CAGR during the forecast period (2020-2026).
Increased mental health awareness and the prevalence of neurological diseases along with numerous initiatives taken up by the government and private entities have been contributing to the exponential market growth. Factors such as improved healthcare infrastructure, an increasing number of healthcare reforms, and extensive healthcare spending in emerging markets such as India and China to overcome unmet medical needs in these regions are boosting demand for neurostimulators.
The rapid rise of COVID-19 infections leads to an increased concern for the shortage of essential life-saving devices and other vital health care to prevent the spread of this pandemic and provide the infected with optimum care. Additionally, for COVID-19 patients, who may require critical care, ventilators act as a vital treatment preference until a pharmacological treatment is developed. In addition, a wide variety of test-kits (antibody samples, self-administered, and others) require a rapid acceleration in the manufacturing process.
In conjunction with the available limited treatment options for the disease, the high product efficiency in the treatment of epilepsy is expected to boost market growth throughout the forecast period. Essential tremor is characterized by severe unintentional limb movement. The condition has an impact on the neck, jaw, and other parts of the body. The rising global population of geriatric diseases is among the most significant causes of tremor. Rising depression cases are also likely to contribute to the market development as neurostimulation equipment can easily handle electrical brain signals by activating or inhibiting them.
Based on Devices, the market is segmented into Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators and Other Devices. Based on Applications, the market is segmented into Pain Management, Hearing Loss, Urinary Incontinence, Parkinson's Disease, Epilepsy and Other Applications. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers theanalysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Boston Scientific Corporation, Nevro Corporation, Medtronic PLC, NeuroSigma, Inc., Integer Holdings Corporation, LivaNova PLC, NeuroPace, Inc., Neuronetics, Inc., and Synapse BioMedical, Inc.
Scope of the Study
Market Segmentation:
By Devices
Increased mental health awareness and the prevalence of neurological diseases along with numerous initiatives taken up by the government and private entities have been contributing to the exponential market growth. Factors such as improved healthcare infrastructure, an increasing number of healthcare reforms, and extensive healthcare spending in emerging markets such as India and China to overcome unmet medical needs in these regions are boosting demand for neurostimulators.
The rapid rise of COVID-19 infections leads to an increased concern for the shortage of essential life-saving devices and other vital health care to prevent the spread of this pandemic and provide the infected with optimum care. Additionally, for COVID-19 patients, who may require critical care, ventilators act as a vital treatment preference until a pharmacological treatment is developed. In addition, a wide variety of test-kits (antibody samples, self-administered, and others) require a rapid acceleration in the manufacturing process.
In conjunction with the available limited treatment options for the disease, the high product efficiency in the treatment of epilepsy is expected to boost market growth throughout the forecast period. Essential tremor is characterized by severe unintentional limb movement. The condition has an impact on the neck, jaw, and other parts of the body. The rising global population of geriatric diseases is among the most significant causes of tremor. Rising depression cases are also likely to contribute to the market development as neurostimulation equipment can easily handle electrical brain signals by activating or inhibiting them.
Based on Devices, the market is segmented into Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators and Other Devices. Based on Applications, the market is segmented into Pain Management, Hearing Loss, Urinary Incontinence, Parkinson's Disease, Epilepsy and Other Applications. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers theanalysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Boston Scientific Corporation, Nevro Corporation, Medtronic PLC, NeuroSigma, Inc., Integer Holdings Corporation, LivaNova PLC, NeuroPace, Inc., Neuronetics, Inc., and Synapse BioMedical, Inc.
Scope of the Study
Market Segmentation:
By Devices
- Spinal Cord Stimulators
- Deep Brain Stimulators
- Sacral Nerve Stimulators
- Vagus Nerve Stimulators and
- Other Devices
- Pain Management
- Hearing Loss
- Urinary Incontinence
- Parkinson's Disease
- Epilepsy and
- Other Applications
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
- Abbott Laboratories
- Boston Scientific Corporation
- Nevro Corporation
- Medtronic PLC
- NeuroSigma, Inc.
- Integer Holdings Corporation
- LivaNova PLC
- NeuroPace, Inc.
- Neuronetics, Inc.
- Synapse BioMedical, Inc.
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Neurostimulation Devices Market, by Devices
1.4.2 Asia Pacific Neurostimulation Devices Market, by Applications
1.4.3 Asia Pacific Neurostimulation Devices Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. COMPETITION ANALYSIS - GLOBAL
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Mergers & Acquisitions
3.2.4 Approvals
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements: 2016, Oct – 2020, May) Leading Players
CHAPTER 4. ASIA PACIFIC NEUROSTIMULATION DEVICES MARKET BY DEVICES
4.1 Asia Pacific Spinal Cord Stimulators Market by Country
4.2 Asia Pacific Deep Brain Stimulators Market by Country
4.3 Asia Pacific Sacral Nerve Stimulators Market by Country
4.4 Asia Pacific Vagus Nerve Stimulators Market by Country
4.5 Asia Pacific Other Devices Market by Country
CHAPTER 5. ASIA PACIFIC NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS
5.1 Asia Pacific Pain Management Market by Country
5.2 Asia Pacific Hearing Loss Market by Country
5.3 Asia Pacific Urinary Incontinence Market by Country
5.4 Asia Pacific Parkinson's Disease Market by Country
5.5 Asia Pacific Epilepsy Market by Country
5.6 Asia Pacific Other Applications Market by Country
CHAPTER 6. ASIA PACIFIC NEUROSTIMULATION DEVICES MARKET BY COUNTRY
6.1 China Neurostimulation Devices Market
6.1.1 China Neurostimulation Devices Market by Devices
6.1.2 China Neurostimulation Devices Market by Applications
6.2 India Neurostimulation Devices Market
6.2.1 India Neurostimulation Devices Market by Devices
6.2.2 India Neurostimulation Devices Market by Applications
6.3 Japan Neurostimulation Devices Market
6.3.1 Japan Neurostimulation Devices Market by Devices
6.3.2 Japan Neurostimulation Devices Market by Applications
6.4 South Korea Neurostimulation Devices Market
6.4.1 South Korea Neurostimulation Devices Market by Devices
6.4.2 South Korea Neurostimulation Devices Market by Applications
6.5 Singapore Neurostimulation Devices Market
6.5.1 Singapore Neurostimulation Devices Market by Devices
6.5.2 Singapore Neurostimulation Devices Market by Applications
6.6 Malaysia Neurostimulation Devices Market
6.6.1 Malaysia Neurostimulation Devices Market by Devices
6.6.2 Malaysia Neurostimulation Devices Market by Applications
6.7 Rest of Asia Pacific Neurostimulation Devices Market
6.7.1 Rest of Asia Pacific Neurostimulation Devices Market by Devices
6.7.2 Rest of Asia Pacific Neurostimulation Devices Market by Applications
CHAPTER 7. COMPANY PROFILES
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.1.5.2 Approvals:
7.2 Boston Scientific Corporation
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Acquisition and Mergers:
7.2.5.2 Product Launches and Product Expansions:
7.3 Nevro Corporation
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Approvals:
7.4 Medtronic PLC
7.4.1 Company overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expenses
7.4.5 Recent strategies and developments:
7.4.5.1 Partnerships, Collaborations, and Agreements:
7.4.5.2 Acquisition and Mergers:
7.4.5.3 Product Launches and Product Expansions:
7.4.5.4 Approvals:
7.5 NeuroSigma, Inc.
7.5.1 Company Overview
7.5.2 Recent strategies and developments:
7.5.2.1 Partnerships, Collaborations, and Agreements:
7.6 Integer Holdings Corporation
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.7 LivaNova PLC
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Approvals:
7.7.5.2 Acquisition and Mergers:
7.8 NeuroPace, Inc.
7.8.1 Company Overview
7.8.2 Recent strategies and developments:
7.8.2.1 Approvals:
7.8.2.2 Product Launches and Product Expansions:
7.9 Neuronetics, Inc.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Regional Analysis
7.9.4 Research & Development Expense
7.9.5 Recent strategies and developments:
7.9.5.1 Partnerships, Collaborations, and Agreements:
7.9.5.2 Approvals:
7.1 Synapse BioMedical, Inc.
7.10.1 Company Overview
7.10.2 Recent strategies and developments:
7.10.2.1 Approvals:
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Neurostimulation Devices Market, by Devices
1.4.2 Asia Pacific Neurostimulation Devices Market, by Applications
1.4.3 Asia Pacific Neurostimulation Devices Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. COMPETITION ANALYSIS - GLOBAL
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Mergers & Acquisitions
3.2.4 Approvals
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements: 2016, Oct – 2020, May) Leading Players
CHAPTER 4. ASIA PACIFIC NEUROSTIMULATION DEVICES MARKET BY DEVICES
4.1 Asia Pacific Spinal Cord Stimulators Market by Country
4.2 Asia Pacific Deep Brain Stimulators Market by Country
4.3 Asia Pacific Sacral Nerve Stimulators Market by Country
4.4 Asia Pacific Vagus Nerve Stimulators Market by Country
4.5 Asia Pacific Other Devices Market by Country
CHAPTER 5. ASIA PACIFIC NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS
5.1 Asia Pacific Pain Management Market by Country
5.2 Asia Pacific Hearing Loss Market by Country
5.3 Asia Pacific Urinary Incontinence Market by Country
5.4 Asia Pacific Parkinson's Disease Market by Country
5.5 Asia Pacific Epilepsy Market by Country
5.6 Asia Pacific Other Applications Market by Country
CHAPTER 6. ASIA PACIFIC NEUROSTIMULATION DEVICES MARKET BY COUNTRY
6.1 China Neurostimulation Devices Market
6.1.1 China Neurostimulation Devices Market by Devices
6.1.2 China Neurostimulation Devices Market by Applications
6.2 India Neurostimulation Devices Market
6.2.1 India Neurostimulation Devices Market by Devices
6.2.2 India Neurostimulation Devices Market by Applications
6.3 Japan Neurostimulation Devices Market
6.3.1 Japan Neurostimulation Devices Market by Devices
6.3.2 Japan Neurostimulation Devices Market by Applications
6.4 South Korea Neurostimulation Devices Market
6.4.1 South Korea Neurostimulation Devices Market by Devices
6.4.2 South Korea Neurostimulation Devices Market by Applications
6.5 Singapore Neurostimulation Devices Market
6.5.1 Singapore Neurostimulation Devices Market by Devices
6.5.2 Singapore Neurostimulation Devices Market by Applications
6.6 Malaysia Neurostimulation Devices Market
6.6.1 Malaysia Neurostimulation Devices Market by Devices
6.6.2 Malaysia Neurostimulation Devices Market by Applications
6.7 Rest of Asia Pacific Neurostimulation Devices Market
6.7.1 Rest of Asia Pacific Neurostimulation Devices Market by Devices
6.7.2 Rest of Asia Pacific Neurostimulation Devices Market by Applications
CHAPTER 7. COMPANY PROFILES
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.1.5.2 Approvals:
7.2 Boston Scientific Corporation
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Acquisition and Mergers:
7.2.5.2 Product Launches and Product Expansions:
7.3 Nevro Corporation
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Approvals:
7.4 Medtronic PLC
7.4.1 Company overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expenses
7.4.5 Recent strategies and developments:
7.4.5.1 Partnerships, Collaborations, and Agreements:
7.4.5.2 Acquisition and Mergers:
7.4.5.3 Product Launches and Product Expansions:
7.4.5.4 Approvals:
7.5 NeuroSigma, Inc.
7.5.1 Company Overview
7.5.2 Recent strategies and developments:
7.5.2.1 Partnerships, Collaborations, and Agreements:
7.6 Integer Holdings Corporation
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.7 LivaNova PLC
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Approvals:
7.7.5.2 Acquisition and Mergers:
7.8 NeuroPace, Inc.
7.8.1 Company Overview
7.8.2 Recent strategies and developments:
7.8.2.1 Approvals:
7.8.2.2 Product Launches and Product Expansions:
7.9 Neuronetics, Inc.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Regional Analysis
7.9.4 Research & Development Expense
7.9.5 Recent strategies and developments:
7.9.5.1 Partnerships, Collaborations, and Agreements:
7.9.5.2 Approvals:
7.1 Synapse BioMedical, Inc.
7.10.1 Company Overview
7.10.2 Recent strategies and developments:
7.10.2.1 Approvals:
LIST OF TABLES
TABLE 1 ASIA PACIFIC NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 2 ASIA PACIFIC NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 3 PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS– NEUROSTIMULATION DEVICES MARKET
TABLE 4 PRODUCT LAUNCHES AND PRODUCT EXPANSIONS– NEUROSTIMULATION DEVICES MARKET
TABLE 5 MERGERS & ACQUISITIONS – NEUROSTIMULATION DEVICES MARKET
TABLE 6 APPROVALS – NEUROSTIMULATION DEVICES MARKET
TABLE 7 ASIA PACIFIC NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 8 ASIA PACIFIC NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 9 ASIA PACIFIC SPINAL CORD STIMULATORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 10 ASIA PACIFIC SPINAL CORD STIMULATORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 11 ASIA PACIFIC DEEP BRAIN STIMULATORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 12 ASIA PACIFIC DEEP BRAIN STIMULATORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 13 ASIA PACIFIC SACRAL NERVE STIMULATORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 14 ASIA PACIFIC SACRAL NERVE STIMULATORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 15 ASIA PACIFIC VAGUS NERVE STIMULATORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 16 ASIA PACIFIC VAGUS NERVE STIMULATORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 17 ASIA PACIFIC OTHER DEVICES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 18 ASIA PACIFIC OTHER DEVICES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 19 ASIA PACIFIC NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 20 ASIA PACIFIC NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 21 ASIA PACIFIC PAIN MANAGEMENT MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 22 ASIA PACIFIC PAIN MANAGEMENT MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 23 ASIA PACIFIC HEARING LOSS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 24 ASIA PACIFIC HEARING LOSS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 25 ASIA PACIFIC URINARY INCONTINENCE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 26 ASIA PACIFIC URINARY INCONTINENCE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 27 ASIA PACIFIC PARKINSON'S DISEASE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 28 ASIA PACIFIC PARKINSON'S DISEASE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 29 ASIA PACIFIC EPILEPSY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 30 ASIA PACIFIC EPILEPSY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 31 ASIA PACIFIC OTHER APPLICATIONS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 32 ASIA PACIFIC OTHER APPLICATIONS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 33 ASIA PACIFIC NEUROSTIMULATION DEVICES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 34 ASIA PACIFIC NEUROSTIMULATION DEVICES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 35 CHINA NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 36 CHINA NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 37 CHINA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 38 CHINA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 39 CHINA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 40 CHINA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 41 INDIA NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 42 INDIA NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 43 INDIA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 44 INDIA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 45 INDIA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 46 INDIA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 47 JAPAN NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 48 JAPAN NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 49 JAPAN NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 50 JAPAN NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 51 JAPAN NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 52 JAPAN NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 53 SOUTH KOREA NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 54 SOUTH KOREA NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 55 SOUTH KOREA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 56 SOUTH KOREA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 57 SOUTH KOREA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 58 SOUTH KOREA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 59 SINGAPORE NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 60 SINGAPORE NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 61 SINGAPORE NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 62 SINGAPORE NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 63 SINGAPORE NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 64 SINGAPORE NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 65 MALAYSIA NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 66 MALAYSIA NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 67 MALAYSIA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 68 MALAYSIA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 69 MALAYSIA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 70 MALAYSIA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 71 REST OF ASIA PACIFIC NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 72 REST OF ASIA PACIFIC NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 73 REST OF ASIA PACIFIC NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 74 REST OF ASIA PACIFIC NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 75 REST OF ASIA PACIFIC NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 76 REST OF ASIA PACIFIC NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 77 KEY INFORMATION – ABBOTT LABORATORIES
TABLE 78 KEY INFORMATION – BOSTON SCIENTIFIC CORPORATION
TABLE 79 KEY INFORMATION – NEVRO CORPORATION
TABLE 80 KEY INFORMATION – MEDTRONIC PLC
TABLE 81 KEY INFORMATION – NEUROSIGMA, INC.
TABLE 82 KEY INFORMATION – INTEGER HOLDINGS CORPORATION
TABLE 83 KEY INFORMATION – LIVANOVA PLC
TABLE 84 KEY INFORMATION – NEUROPACE, INC.
TABLE 85 KEY INFORMATION – NEURONETICS, INC.
TABLE 86 KEY INFORMATION – SYNAPSE BIOMEDICAL, INC.
TABLE 1 ASIA PACIFIC NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 2 ASIA PACIFIC NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 3 PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS– NEUROSTIMULATION DEVICES MARKET
TABLE 4 PRODUCT LAUNCHES AND PRODUCT EXPANSIONS– NEUROSTIMULATION DEVICES MARKET
TABLE 5 MERGERS & ACQUISITIONS – NEUROSTIMULATION DEVICES MARKET
TABLE 6 APPROVALS – NEUROSTIMULATION DEVICES MARKET
TABLE 7 ASIA PACIFIC NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 8 ASIA PACIFIC NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 9 ASIA PACIFIC SPINAL CORD STIMULATORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 10 ASIA PACIFIC SPINAL CORD STIMULATORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 11 ASIA PACIFIC DEEP BRAIN STIMULATORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 12 ASIA PACIFIC DEEP BRAIN STIMULATORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 13 ASIA PACIFIC SACRAL NERVE STIMULATORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 14 ASIA PACIFIC SACRAL NERVE STIMULATORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 15 ASIA PACIFIC VAGUS NERVE STIMULATORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 16 ASIA PACIFIC VAGUS NERVE STIMULATORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 17 ASIA PACIFIC OTHER DEVICES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 18 ASIA PACIFIC OTHER DEVICES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 19 ASIA PACIFIC NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 20 ASIA PACIFIC NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 21 ASIA PACIFIC PAIN MANAGEMENT MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 22 ASIA PACIFIC PAIN MANAGEMENT MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 23 ASIA PACIFIC HEARING LOSS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 24 ASIA PACIFIC HEARING LOSS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 25 ASIA PACIFIC URINARY INCONTINENCE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 26 ASIA PACIFIC URINARY INCONTINENCE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 27 ASIA PACIFIC PARKINSON'S DISEASE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 28 ASIA PACIFIC PARKINSON'S DISEASE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 29 ASIA PACIFIC EPILEPSY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 30 ASIA PACIFIC EPILEPSY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 31 ASIA PACIFIC OTHER APPLICATIONS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 32 ASIA PACIFIC OTHER APPLICATIONS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 33 ASIA PACIFIC NEUROSTIMULATION DEVICES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 34 ASIA PACIFIC NEUROSTIMULATION DEVICES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 35 CHINA NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 36 CHINA NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 37 CHINA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 38 CHINA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 39 CHINA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 40 CHINA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 41 INDIA NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 42 INDIA NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 43 INDIA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 44 INDIA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 45 INDIA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 46 INDIA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 47 JAPAN NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 48 JAPAN NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 49 JAPAN NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 50 JAPAN NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 51 JAPAN NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 52 JAPAN NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 53 SOUTH KOREA NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 54 SOUTH KOREA NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 55 SOUTH KOREA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 56 SOUTH KOREA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 57 SOUTH KOREA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 58 SOUTH KOREA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 59 SINGAPORE NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 60 SINGAPORE NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 61 SINGAPORE NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 62 SINGAPORE NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 63 SINGAPORE NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 64 SINGAPORE NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 65 MALAYSIA NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 66 MALAYSIA NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 67 MALAYSIA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 68 MALAYSIA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 69 MALAYSIA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 70 MALAYSIA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 71 REST OF ASIA PACIFIC NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 72 REST OF ASIA PACIFIC NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 73 REST OF ASIA PACIFIC NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 74 REST OF ASIA PACIFIC NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 75 REST OF ASIA PACIFIC NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 76 REST OF ASIA PACIFIC NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 77 KEY INFORMATION – ABBOTT LABORATORIES
TABLE 78 KEY INFORMATION – BOSTON SCIENTIFIC CORPORATION
TABLE 79 KEY INFORMATION – NEVRO CORPORATION
TABLE 80 KEY INFORMATION – MEDTRONIC PLC
TABLE 81 KEY INFORMATION – NEUROSIGMA, INC.
TABLE 82 KEY INFORMATION – INTEGER HOLDINGS CORPORATION
TABLE 83 KEY INFORMATION – LIVANOVA PLC
TABLE 84 KEY INFORMATION – NEUROPACE, INC.
TABLE 85 KEY INFORMATION – NEURONETICS, INC.
TABLE 86 KEY INFORMATION – SYNAPSE BIOMEDICAL, INC.
LIST OF FIGURES
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 KBV CARDINAL MATRIX
FIG 3 KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2016-2020)
FIG 4 KEY STRATEGIC MOVE: (PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS: 2016, OCT – 2020, MAY) LEADING PLAYERS
FIG 5 RECENT STRATEGIES AND DEVELOPMENTS: BOSTON SCIENTIFIC CORPORATION
FIG 6 RECENT STRATEGIES AND DEVELOPMENTS: MEDTRONIC PLC
FIG 7 RECENT STRATEGIES AND DEVELOPMENTS: LIVANOVA PLC
FIG 8 RECENT STRATEGIES AND DEVELOPMENTS: NEUROPACE, INC.
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 KBV CARDINAL MATRIX
FIG 3 KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2016-2020)
FIG 4 KEY STRATEGIC MOVE: (PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS: 2016, OCT – 2020, MAY) LEADING PLAYERS
FIG 5 RECENT STRATEGIES AND DEVELOPMENTS: BOSTON SCIENTIFIC CORPORATION
FIG 6 RECENT STRATEGIES AND DEVELOPMENTS: MEDTRONIC PLC
FIG 7 RECENT STRATEGIES AND DEVELOPMENTS: LIVANOVA PLC
FIG 8 RECENT STRATEGIES AND DEVELOPMENTS: NEUROPACE, INC.
